We have generated herpes simplex virus (HSV) vectors vIE1GT and va4GT bearing the GLUT-1 isoform of the rat brain glucose transporter (GT) under the control of the human cytomegalovirus iel and HSV a4 promoters, respectively. We previously reported that such vectors enhance glucose uptake in hippocampal cultures and the hippocampus. In this study we demonstrate that such vectors can maintain neuronal metabolism and reduce the extent of neuron loss in cultures after a period of hypoglycemia. Microinfusion of GT vectors into the rat hippocampus also reduces kainic acid-induced seizure damage in the CA3 cell field. Furthermore, delivery of the vector even after onset of the seizure is protective, suggesting that HSV-mediated gene transfer for neuroprotection need not be carried out in anticipation of neurologic crises. Using the bicistronic vector va22j3gala4GT, which coexpresses both GT and the Escherichia coli lacZ marker gene, we further demonstrate an inverse correlation between the extent of vector expression in the dentate and the amount of CA3 damage resulting from the simultaneous delivery of kainic acid.Given their postmitotic nature, neurons lost to stroke, seizure, hypoglycemia, hypoxia, and brain trauma are irreplaceable, and the neurologic consequences of such events are often permanently debilitating. Interventions that impede neuron death, such as those that prevent glutamate release, block N-methyl-Dasparate receptor activation, decrease cytosolic Ca2+ concentrations, reduce oxygen radical damage, or bolster metabolism, are therefore of critical interest. With the aim of establishing gene transfer methods that might provide effective interventions, herpes simplex virus (HSV) vectors have been used to deliver reporter genes (1) and other more physiologically relevant genes (2-5) to central nervous system neurons.In our first application of HSV-mediated gene transfer, we targeted the energetic disruptions that are intrinsic to the necrotic neuron death that follows neurological insults (6-8). By pursuing this strategy, we have generated HSV vectors bearing the GLUT-1 isoform of the rat brain glucose transporter (GT). We previously found that such vectors enhance glucose uptake in hippocampal cultures and in the hippocampus in vivo (9). We have now extended our investigation to test whether increased glucose uptake might be neuroprotective. In this report, we demonstrate that infection with GT-bearing HSV vectors resulted in resistance to hypoglycemia in vitro, which enhanced both metabolism and neuron survival. Moreover, microinfusion of such vectors into the hippocampus reduced kainic acid (KA)-induced seizure damage in vivo. Most importantly, in terms of the therapeutic efficacy of gene transfer strategies, such an intervention was found to be protective even when carried out after, rather than in anticipation of, the seizure.MATERIALS AND METHODS Cells and Virus. Mixed neuronal/glial hippocampal cultures were prepared as described (9). Neuron-to-glia ratios were assessed by immunocytochemic...